BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li C, Li R, Zhang W. Progress in non-invasive detection of liver fibrosis. Cancer Biol Med 2018;15:124-36. [PMID: 29951337 DOI: 10.20892/j.issn.2095-3941.2018.0018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Zeng DB, Di L, Zhang RC, Guo QL, Duan BW, Jia CY, Chen F, Lin DD, Zang YJ, Lu SC. The Effect of Splenectomy on the Reversal of Cirrhosis: a Prospective Study. Gastroenterol Res Pract. 2019;2019:5459427. [PMID: 31093275 DOI: 10.1155/2019/5459427] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Li MH, Lu Y, Zhang L, Wang XY, Ran CP, Hao HX, Zhang D, Qu XJ, Shen G, Wu SL, Cao WH, Qi TL, Liu RY, Hu LP, Chang M, Hua WH, Liu SA, Wan G, Xie Y. Association of Cytokines with Alanine Aminotransferase, Hepatitis B Virus Surface Antigen and Hepatitis B Envelope Antigen Levels in Chronic Hepatitis B. Chin Med J (Engl) 2018;131:1813-8. [PMID: 30058578 DOI: 10.4103/0366-6999.237394] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Lin CC, Wu CH, Chen LY, Tsai MC, Elsarawy AM, Huang KT. Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases. Cancer Biol Med 2018;15:275-81. [PMID: 30197794 DOI: 10.20892/j.issn.2095-3941.2017.0144] [Reference Citation Analysis]
4 Fan G, Ya Y, Ni X, Hou J, Yu R. Application Value of Magnetic Resonance Perfusion Imaging in the Early Diagnosis of Rat Hepatic Fibrosis. Biomed Res Int 2019;2019:5095934. [PMID: 31950040 DOI: 10.1155/2019/5095934] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Li C, Zhu A. Application of Image Fusion in Diagnosis and Treatment of Liver Cancer. Applied Sciences 2020;10:1171. [DOI: 10.3390/app10031171] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
6 Xu M, Zhu S, Xu R, Lin N. Identification of CELSR2 as a novel prognostic biomarker for hepatocellular carcinoma. BMC Cancer 2020;20:313. [PMID: 32293343 DOI: 10.1186/s12885-020-06813-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chen LZ, Jing XB, Wu CF, Zeng YC, Xie YC, Wang MQ, Chen WX, Hu X, Zhou YN, Cai XB. Nonalcoholic Fatty Liver Disease-Associated Liver Fibrosis Is Linked with the Severity of Coronary Artery Disease Mediated by Systemic Inflammation. Dis Markers 2021;2021:6591784. [PMID: 34992694 DOI: 10.1155/2021/6591784] [Reference Citation Analysis]
8 Ghandian S, Thapa R, Garikipati A, Barnes G, Green‐saxena A, Calvert J, Mao Q, Das R. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosis. JGH Open. [DOI: 10.1002/jgh3.12716] [Reference Citation Analysis]
9 Li Q, Yu B, Tian X, Cui X, Zhang R, Guo Q. Deep residual nets model for staging liver fibrosis on plain CT images. Int J Comput Assist Radiol Surg 2020;15:1399-406. [PMID: 32556922 DOI: 10.1007/s11548-020-02206-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Yun HH, Park S, Chung MJ, Son JY, Park JM, Jung SJ, Yim JH, Kang KK, Byeon S, Baek SM, Lee SW, Lee AR, Kim TH, Park JK, Jeong KS. Effects of losartan and l-serine in a mouse liver fibrosis model. Life Sci 2021;278:119578. [PMID: 33965379 DOI: 10.1016/j.lfs.2021.119578] [Reference Citation Analysis]
11 Niu LJ, Zhang YM, Huang T, Sun XF, Luo SX. Exosomal microRNA-155 as a biomarker for hepatic fibrosis diagnosis and progression. Ann Transl Med 2021;9:137. [PMID: 33569439 DOI: 10.21037/atm-20-7787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Bai Y, Xie F, Miao F, Long J, Huang S, Huang H, Lin J, Wang D, Yang X, Bian J, Mao J, Wang X, Mao Y, Sang X, Zhao H. The diagnostic and prognostic role of RhoA in hepatocellular carcinoma. Aging (Albany NY) 2019;11:5158-72. [PMID: 31339860 DOI: 10.18632/aging.102110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Zhang Q, Lou Y, Yang J, Wang J, Feng J, Zhao Y, Wang L, Huang X, Fu Q, Ye M, Zhang X, Chen Y, Ma C, Ge H, Wu J, Wei T, Chen Q, Yu C, Xiao Y, Feng X, Guo G, Liang T, Bai X. Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas. Gut. 2019;68:2019-2031. [PMID: 31227589 DOI: 10.1136/gutjnl-2019-318912] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 21.7] [Reference Citation Analysis]
14 O'Shea A, Pierce TT. US Elastography in Hepatic Fibrosis-Radiology In Training. Radiology 2021;299:264-71. [PMID: 33754829 DOI: 10.1148/radiol.2021203893] [Reference Citation Analysis]
15 Xu M, Liang H, Li K, Zhu S, Yao Z, Xu R, Lin N. Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging (Albany NY) 2021;13:5263-83. [PMID: 33535183 DOI: 10.18632/aging.202447] [Reference Citation Analysis]
16 Bai Y, Long J, Liu Z, Lin J, Huang H, Wang D, Yang X, Miao F, Mao Y, Sang X, Zhao H. Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression. J Cell Physiol 2019;234:18837-48. [PMID: 30916406 DOI: 10.1002/jcp.28522] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 14.3] [Reference Citation Analysis]
17 Xiang S, Lu L, Zhong H, Lu M, Mao H. SERS diagnosis of liver fibrosis in the early stage based on gold nanostar liver targeting tags. Biomater Sci 2021;9:5035-44. [PMID: 34110332 DOI: 10.1039/d1bm00013f] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Metra BM, Guglielmo FF, Halegoua-DeMarzio DL, Civan JM, Mitchell DG. Beyond the Liver Function Tests: A Radiologist's Guide to the Liver Blood Tests. Radiographics 2021;:210137. [PMID: 34797734 DOI: 10.1148/rg.210137] [Reference Citation Analysis]
19 Zhu Y, Li ZY, Wang CG, Fang ZP, Jia WD, Zhang FB. Laparoscopic combined with thoracoscopic transdiaphragmatic hepatectomy for hepatitis B-related hepatocellular carcinoma located in segment VII or VIII. Hepatobiliary Pancreat Dis Int 2020;19:291-4. [PMID: 31862345 DOI: 10.1016/j.hbpd.2019.11.002] [Reference Citation Analysis]
20 Poo JL, Torre A, Aguilar-Ramírez JR, Cruz M, Mejía-Cuán L, Cerda E, Velázquez A, Patiño A, Ramírez-Castillo C, Cisneros L, Bosques-Padilla F, Hernández L, Gasca F, Flores-Murrieta F, Treviño S, Tapia G, Armendariz-Borunda J, Muñoz-Espinosa LE. Benefits of prolonged-release pirfenidone plus standard of care treatment in patients with advanced liver fibrosis: PROMETEO study. Hepatol Int 2020;14:817-27. [PMID: 32813194 DOI: 10.1007/s12072-020-10069-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
21 Bai Y, Zhao H. Liquid biopsy in tumors: opportunities and challenges. Ann Transl Med 2018;6:S89. [PMID: 30613664 DOI: 10.21037/atm.2018.11.31] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
22 Smorodin E, Sergeyev B, Kurtenkov O, Kuznetsova T, Geller J. IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment. Dis Markers 2018;2018:4639805. [PMID: 30627223 DOI: 10.1155/2018/4639805] [Reference Citation Analysis]
23 Liu S, Liu H, Dong Y, Wang F, Wang H, Chen J. Gastric carcinoma with a gastrointestinal stromal tumor - A case report and literature review. Med Sci (Paris) 2018;34 Focus issue F1:15-9. [PMID: 30403169 DOI: 10.1051/medsci/201834f103] [Reference Citation Analysis]
24 Chen H, Dai S, Fang Y, Chen L, Jiang K, Wei Q, Ding K. Hepatic Steatosis Predicts Higher Incidence of Recurrence in Colorectal Cancer Liver Metastasis Patients. Front Oncol 2021;11:631943. [PMID: 33767997 DOI: 10.3389/fonc.2021.631943] [Reference Citation Analysis]
25 Zeng S, Zeng N, Zhu W, Xiang N, Yang J, Wen S, Fang C. [Three-dimensional visualization combined with indocyanine green fluorescence imaging in diagnosis and treatment of primary hepatocellular carcinoma]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1402-8. [PMID: 31907149 DOI: 10.12122/j.issn.1673-4254.2019.12.03] [Reference Citation Analysis]
26 Behairy OG, El-bakry MM, Mansour AI, Abdelrahman AMN, Emam GM. Matrix metalloproteinase-1 as a non-invasive biomarker to assess liver fibrosis in children with chronic liver disease. Egypt Liver Journal 2021;11. [DOI: 10.1186/s43066-021-00148-x] [Reference Citation Analysis]
27 Feng H, Li B, Li Z, Wei Q, Ren L. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer 2021;21:401. [PMID: 33849479 DOI: 10.1186/s12885-021-08138-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wang X, Wu B. Critical issues in the diagnosis and treatment of liver cirrhosis. Gastroenterol Rep (Oxf) 2019;7:227-30. [PMID: 31413829 DOI: 10.1093/gastro/goz024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Zhuang H, Wu F, Wei W, Dang Y, Yang B, Ma X, Han F, Li Y. Glycine decarboxylase induces autophagy and is downregulated by miRNA-30d-5p in hepatocellular carcinoma. Cell Death Dis 2019;10:192. [PMID: 30804330 DOI: 10.1038/s41419-019-1446-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
30 Fang C, Zhang P, Qi X. Digital and intelligent liver surgery in the new era: Prospects and dilemmas. EBioMedicine 2019;41:693-701. [PMID: 30773479 DOI: 10.1016/j.ebiom.2019.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
31 Balachandran YL, Wang W, Yang H, Tong H, Wang L, Liu F, Chen H, Zhong K, Liu Y, Jiang X. Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis. ACS Nano 2022. [PMID: 35312295 DOI: 10.1021/acsnano.1c10618] [Reference Citation Analysis]
32 Long J, Wang A, Bai Y, Lin J, Yang X, Wang D, Yang X, Jiang Y, Zhao H. Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma. EBioMedicine. 2019;42:363-374. [PMID: 30885723 DOI: 10.1016/j.ebiom.2019.03.022] [Cited by in Crossref: 73] [Cited by in F6Publishing: 84] [Article Influence: 24.3] [Reference Citation Analysis]
33 Joshi A, Muthe MM, Firke V, Badgujar H. Preliminary experience with 3T magnetic resonance elastography imaging of the liver. SA J Radiol 2021;25:2072. [PMID: 34192073 DOI: 10.4102/sajr.v25i1.2072] [Reference Citation Analysis]
34 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Xie F, Feng S, Sun L, Mao Y. The first-line treatment for unresectable hepatocellular carcinoma patients: lenvatinib versus sorafenib, or beyond? Hepatobiliary Surg Nutr 2018;7:221-4. [PMID: 30046580 DOI: 10.21037/hbsn.2018.06.06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 Li L, Wang G, Hu JS, Zhang GQ, Chen HZ, Yuan Y, Li YL, Lv XJ, Tian FY, Pan SH, Bai XW, Sun B. RB1CC1-enhanced autophagy facilitates PSCs activation and pancreatic fibrogenesis in chronic pancreatitis. Cell Death Dis 2018;9:952. [PMID: 30237496 DOI: 10.1038/s41419-018-0980-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
37 Zhang Y, Chen S. Reconsider minimally invasive surgery for early cervical cancer. Ann Transl Med 2019;7:S111. [PMID: 31576318 DOI: 10.21037/atm.2019.05.25] [Reference Citation Analysis]
38 Timsaal Y, Ali SH, Malik F, Chawla A, Ahmed J. Rare Case of Budd-Chiari Syndrome in a Young Child: A Diagnostic Conundrum. Cureus 2021;13:e16407. [PMID: 34414043 DOI: 10.7759/cureus.16407] [Reference Citation Analysis]